Methotrexate vs Upadacitinib
Methotrexate vs Upadacitinib: Overview
This comparison examines the pharmacological differences between Methotrexate and Upadacitinib.
Mechanism of Action
Methotrexate: Dihydrofolate reductase inhibitor.
Upadacitinib: Selective JAK1 inhibitor reducing signaling from cytokines implicated in autoimmune diseases.
Pharmacokinetics
Half-life: Methotrexate — 3-10 hours; Upadacitinib — 9-14 hours.
Chemical Properties
Molecular Formula: Methotrexate — C20H22N8O5; Upadacitinib — C17H19F3N6O.
Molecular Weight: Methotrexate — 454.4400 g/mol; Upadacitinib — 380.3700 g/mol.
Type: Methotrexate — Small molecule; Upadacitinib — Small molecule.